Bio Port Korea KRX:188040KOSDAQ

바이오포트 · Korean news coverage and regulatory filings, organized.

Articles, 24h3
Articles, 7 days3
DART filings, 7 days0
Articles tracked3since Sep 11

In Q2 2026, Bio Port Korea reported revenue of ₩21.8bn, up 13.4% year on year, and operating profit of ₩1.5bn. Bio Port Korea (바이오포트) appeared in 3 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 15 with 3 articles.

Bio Port Korea quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩21.8bn+13.4%₩1.5bn₩1.7bn
Q1 2026₩21.4bn+26.8%₩765m₩710m
Q4 2025 derived₩15.7bn-16.0%−₩422m₩42m
Q3 2025₩19.1bn+7.1%₩525m₩528m
Q2 2025₩19.2bn+13.0%₩747m−₩2.0bn
Q1 2025₩16.9bn−₩20m₩37m
Q4 2024 derived₩18.7bn₩1.9bn₩2.4bn
Q3 2024₩17.8bn₩569m₩247m

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Bio Port Korea top stories 2 weeks, by number of outlets

  1. 1
    바이오포트, '두바이 쫀득 찹쌀떡' 대만 판매 호조
    3 outlets · 3 articlesFirst report Sep 15 10:13 뉴스핌

Latest Bio Port Korea news Korean headlines